Additional Titles: Health and Health Care in Kansas

الموضوعات: Vital statistics., Public health Statistics. Kansas, Hospital utilization Statistics. Kansas, Wounds and injuries Registers. Treatment Kansas, Asthma Statistics. Treatment Age factors Kansas, Pulmonary hypertension Statistics. Treatment Kansas, Breast Statistics. Cancer Treatment Kansas, Breast Cancer Treatment Costs. Kansas, Medical care, Cost of Statistics. Kansas, Colon (Anatomy) Cancer Prevention. Kansas, Rectum Cancer Prevention. Kansas, Hand washing Study and teaching (Early childhood) Activity programs Kansas., Hand washing Study and teaching (Elementary) Activity programs Kansas., Physicians Statistics. Age factors Kansas, Physicians Statistics. Supply and demand Age factors Kansas, Medical personnel Statistics. Supply and demand Kansas, Medical personnel Statistics. Supply and demand Age factors Kansas, Osteopathic physicians Supply and demand Forecasting. Kansas, Nurse practitioners Statistics. Supply and demand Kansas, Nurses Supply and demand Forecasting. Kansas, Dentists Statistics. Supply and demand Kansas, Santé publique Statistiques. Kansas, Hôpitaux Statistiques. Utilisation Kansas, Lésions et blessures Registres. Traitement Kansas, Asthme Statistiques. Traitement Facteurs liés à l'âge Kansas, Hypertension pulmonaire Statistiques. Traitement Kansas, Sein Statistiques. Cancer Traitement Kansas, Sein Cancer Traitement Coût. Kansas, Soins médicaux Statistiques. Coût Kansas, Lavage des mains Étude et enseignement (Première enfance) Méthodes actives Kansas., Lavage des mains Étude et enseignement (Primaire) Méthodes actives Kansas., Médecins Statistiques. Facteurs liés à l'âge Kansas, Personnel médical Statistiques. Offre et demande Kansas, Personnel médical Statistiques. Offre et demande Facteurs liés à l'âge Kansas, Breast Cancer Treatment., Colon (Anatomy) Cancer Prevention., Dentists Supply and demand., Hospital utilization., Medical care, Cost of., Medical personnel Supply and demand., Nurse practitioners Supply and demand., Nurses Supply and demand Forecasting., Public health., Rectum Cancer Prevention., Vital statistics., Wounds and injuries Treatment., Kansas.

مصطلحات الفهرس: Registers (Lists), Statistics.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/923316343/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

مصطلحات موضوعية: Medicare -- Law and legislation., Medicaid -- Law and legislation., Waiver -- United States., Emergency management -- United States., COVID-19 (Disease) -- Treatment -- Costs. -- United States, Coronavirus infections -- Treatment -- Costs. -- United States

الوصول للمادة أونلاين: https://purl.fdlp.gov/GPO/gpo135538
https://www.cms.gov/files/document/summary-covid-19-emergency-declaration-waivers.pdf
https://catalog.gpo.gov/fdlpdir/locate.jsp?ItemNumber=0512-A-01&SYS=001118796

المؤلفون: United States. Federal Emergency Management Agency

مصطلحات موضوعية: COVID-19 (Disease) -- Treatment -- Costs. -- United States, Federal aid to health facilities -- United States.

Other Titles: Medical care costs eligible for public assistance
Coronavirus (coronavirus disease 2019) pandemic: medical care costs eligible for public assistance

الوصول للمادة أونلاين: https://purl.fdlp.gov/GPO/gpo141745
https://www.fema.gov/media-library-data/1589208038530-19c77b9558076c303b4ebec5f0631697/PA_Medical_Care_Policy_for_COVID-19_508.pdf
https://catalog.gpo.gov/fdlpdir/locate.jsp?ItemNumber=0520-E-30&SYS=001126119

المؤلفون: Nemanja Petrović, Miloš Milosavljević, Refet Gojak, Miralem Đešević, Dragana Lakić, Ivana Stević, Slobodan Janković

المصدر: Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)

مصطلحات موضوعية: Diabetes mellitus type 2, diabetes complications, treatment costs, healthcare utilization, factors associated, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1310-2818; https://doaj.org/toc/1314-3530

URL الوصول: https://doaj.org/article/5c4a20ced41643f1800950b2906c88a0

المؤلفون: Amarjargal Tsengel, Sergelen Orgoi, Otgonbayar Damdinbazar, Bat-Ireedui Badarch, Urnultsaikhan Ganbold, Batsaikhan Batsuuri, Yerkyebulan Mukhtar, Batsaikhan Bat-Erdene, Liu Lei, Tserenbat Bazarsad, Undarmaa Zandanbazar, Gantugs Yundendorj

المصدر: Health Economics Review, Vol 14, Iss 1, Pp 1-8 (2024)

مصطلحات موضوعية: Liver transplant surgery, Treatment costs, Disease severity, Mongolia, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2191-1991

URL الوصول: https://doaj.org/article/60b58c9283884057a9023942b88d82ae

المؤلفون: Lu Han, Kuixu Lan, Dejian Kou, Zehua Meng, Jin Feng, Elizabeth Maitland, Stephen Nicholas, Jian Wang

المصدر: Health Economics Review, Vol 14, Iss 1, Pp 1-9 (2024)

مصطلحات موضوعية: Cost-effectiveness, Endovascular treatment, Intravenous thrombolysis, Acute ischemic stroke, Direct treatment costs, Indirect costs, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2191-1991

URL الوصول: https://doaj.org/article/10b215e587dd4097852da406f943e720

المؤلفون: Marta Parera Roig, David Compte Colomé, Gemma Basagaña Colomer, Emilia Gabriela Sardo, Mauricio Alejandro Tournour, Silvia Griñó Fernández, Arturo Ivan Ominetti, Emma Puigoriol Juvanteny, José Luis Molinero Polo, Daniel Badia Jobal, Nadia Espejo-Herrera

المصدر: Current Oncology, Vol 31, Iss 4, Pp 2145-2157 (2024)

مصطلحات موضوعية: lung cancer, NSCLC: non-small-cell lung cancer, oncological treatment costs, health economics, real-world data, cancer survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1718-7729/31/4/159; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

URL الوصول: https://doaj.org/article/91e0c5c6c8fe421d80df10fbc6eac839

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Regression_equations_of_models_/24932191

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s002
https://figshare.com/articles/journal_contribution/Regression_equations_of_models_/24932191

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Price_negotiation_in_China_/24932188

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s001
https://figshare.com/articles/journal_contribution/Price_negotiation_in_China_/24932188

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_control_variables_for_indications_supported_by_randomized_controlled_trials_after_price_negotiation_in_China_/24932209

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s008
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_control_variables_for_indications_supported_by_randomized_controlled_trials_after_price_negotiation_in_China_/24932209

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Information_on_27_indications_of_anticancer_drugs_supported_by_single-arm_clinical_trials_in_China_/24932203

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s006
https://figshare.com/articles/journal_contribution/Information_on_27_indications_of_anticancer_drugs_supported_by_single-arm_clinical_trials_in_China_/24932203

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Overview_of_variables_/24932197

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s004
https://figshare.com/articles/journal_contribution/Overview_of_variables_/24932197

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Information_on_76_indications_of_anticancer_drugs_supported_by_randomized_controlled_trials_in_China_/24932200

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s005
https://figshare.com/articles/journal_contribution/Information_on_76_indications_of_anticancer_drugs_supported_by_randomized_controlled_trials_in_China_/24932200

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_control_variables_for_indications_supported_by_randomized_controlled_trials_before_price_negotiation_in_China_/24932206

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s007
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_control_variables_for_indications_supported_by_randomized_controlled_trials_before_price_negotiation_in_China_/24932206

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_control_variables_for_indications_supported_by_single-arm_clinical_trials_before_price_negotiation_in_China_/24932215

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s010
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_control_variables_for_indications_supported_by_single-arm_clinical_trials_before_price_negotiation_in_China_/24932215

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_interaction_terms_and_control_variables_for_indications_supported_by_randomized_controlled_trials_in_China_/24932212

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s009
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_clinical_value_including_interaction_terms_and_control_variables_for_indications_supported_by_randomized_controlled_trials_in_China_/24932212

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_control_variables_for_indications_supported_by_single-arm_clinical_trials_after_price_negotiation_in_China_/24932218

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s011
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_control_variables_for_indications_supported_by_single-arm_clinical_trials_after_price_negotiation_in_China_/24932218

المؤلفون: Jing Zhou, Tianjiao Lan, Hao Lu, Jay Pan

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, randomized controlled trials, overall response rate, consulting review reports, pivotal clinical trials, arm clinical trials, outcome measures based, drugs already listed, based strategic purchase, drug labels issued, substantial price reductions, anticancer drugs even, study limitations include, publicly available prices, iqr ): 19, clinical value may, median treatment costs, calculated treatment costs, price negotiation (<, anticancer drug indications, anticancer drugs, clinical value, drug costs, drug evaluation

Relation: https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_interaction_terms_and_control_variables_for_indications_supported_by_single-arm_clinical_trials_in_China_/24932221

الاتاحة: https://doi.org/10.1371/journal.pmed.1004332.s012
https://figshare.com/articles/journal_contribution/Associations_between_treatment_costs_and_ORR_including_interaction_terms_and_control_variables_for_indications_supported_by_single-arm_clinical_trials_in_China_/24932221

المؤلفون: Konstantin Schlick, Antonia Gantschnigg, Alexander Seymer, Florian Huemer, Richard Greil, Lukas Weiss

المصدر: Cancer Medicine, Vol 12, Iss 16, Pp 16997-17004 (2023)

مصطلحات موضوعية: gemcitabine, GEMOX, nab‐paclitaxel, oxaliplatin, pancreatic cancer, treatment costs, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/b9a49e1c5b3e43409a6abf40578766f3

المؤلفون: Dhika Surya Pangestu, Sukono, Nursanti Anggriani, Najib Majdi Yaacob

المصدر: Computation, Vol 12, Iss 7, p 139 (2024)

مصطلحات موضوعية: pandemic, treatment costs, epidemiological models, trade-off models, Electronic computers. Computer science, QA75.5-76.95

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2079-3197/12/7/139; https://doaj.org/toc/2079-3197

URL الوصول: https://doaj.org/article/39e7ff53f63d4a1993ec9cf394293a15